Nature Biotechnology provides reviews, perspectives and commentaries illuminating topics of particular interest.
2006
MAQC Consortium This supplement collects together reprints of papers from Nature Biotechnology reporting the first formal results of a consortium of over 150 regulatory, industrial and academic scientists that set out to conduct a cross-platform analysis of DNA microarray expression data obtained from two, commercially available RNA samples. October Vol 24, Issue 10s
2004
Health Biotechnology Innovation in Developing Countries The Health Biotechnology Innovation in Developing Countries supplement presents the results of an in-depth study of the health biotechnology sector of seven developing nations. It demonstrates how poorer nations can successfully exploit the biotechnology sector to build their own wealth and improve the well being of their own people. The study is the brainchild of a group of researchers at the Canadian Program on Genomic and Global Health at the University of Toronto Joint Centre for Bioethics. December Vol 22, Issue 12s
2000
Industry Trends Industry Trends supplement is a collection of both original and updated previously published articles from Aris Persidis' Industry Trends column, which has been published on a regular basis in Nature Biotechnology from 1997 to 1999. Each article provides a concise summary of the historical evolution, current state, challenges, and possible future directions of a biotechnology field. As a collection, the articles provide concise snapshots of biotechnology's fastest-moving areas in a format that allows easy comparison. October Vol 18, Issue 10s
1999
BioVision The Nature Biotechnology BioVision supplement contains a diverse set of articles that discuss the potential of biotechnology for improving the quality and duration of life in the coming millennium. Concomitant with the first BioVision meeting in Lyon, France, March 26-29, 1999, the supplement provides a forum for leaders in science, business, and social and cultural thinking to debate the importance of biotechnology in addressing global issues such as population growth, human health, the environment, and their societal, cultural, and political repercussions. February Vol 17, Issue 2s
1998
Pharmacogenomics The Nature Biotechnology Pharmacogenomics Supplement brings together articles exploring the importance of genetic variation in drug development that have previously been published in the journal. It captures the excitement surrounding this field, presents the rationale behind diagnostic-led treatment, and outlines the commercial opportunities attendant with the move toward individualized medicine. February Vol 16, Issue 2s
